Galderma Anchors U.S. and Latin America Operations in Miami with New Headquarters
Event summary
- Galderma officially opened its U.S. and Latin America headquarters in Miami's Brickell district on August 24, 2026.
- The company plans to employ approximately 200 people in Miami, consolidating key leadership teams to strengthen collaboration.
- Galderma has committed over $650 million to U.S. manufacturing investments through 2030, complementing the new headquarters.
- The facility includes a dedicated injection room for healthcare professional training and an ALASTIN Signature Practice experience installation.
The big picture
Galderma's move to Miami underscores the strategic importance of the U.S. market, its largest, where it recorded $3.134 billion in H1 2026 net sales—a 24.6% year-on-year increase. The headquarters opening aligns with broader industry trends of consolidating operations in high-growth regions to enhance agility and talent acquisition. With a portfolio spanning Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology, Galderma is positioning itself as a dermatology powerhouse, leveraging Miami's connectivity to Latin America for further expansion.
What we're watching
- Market Penetration
- How Galderma's Miami hub will accelerate its dominance in the U.S. dermatology market, particularly in aesthetics and skincare.
- Operational Synergies
- Whether consolidating leadership teams in Miami will improve decision-making speed and cross-regional collaboration.
- Investment Impact
- The pace at which Galderma's $650 million U.S. manufacturing investment will translate into product innovation and market share gains.
Related topics